Clinical Trial – Participate

This clinical study is studying adults with metastatic castration-resistant prostate cancer (mCRPC).

Compensation: Reiumbursement Available

Recruiting men at least 18 years old that have been diagnosed with a stricture and have experienced significant symptoms such as frequency of urination, urgency, and slow urine flow.

Compensation: Up to $750

Enrolling patients with bladder cancer, 18 < 90 years old with low to intermediate risk of non-muscle invasive bladder cancer.

Study treatment and study-specific procedures 

Recruiting men on active surveillance for newly diagnosed prostate cancer.

Compensation: Up to $750

Recruiting patients with unresponsive, high-risk, non-muscle invasive bladder cancer. These patients are unresponsive to BCG treatment. Some exclusions include prior chemotherapy or immunotherapy.

Compensation: Up to $900

Enrolling men 50 years old and above in a single-arm BPH study for patients with a diagnosis of very large prostates (80 – 150 grams).

Compensation: Up to $550